Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly Watch These Coinbase Price Levels After Stock's 20% Drop in ...

Analysts have recently evaluated Eli Lilly and provided 12-month price targets. The average target is $955.64, accompanied by a high estimate of $1125.00 and a low estimate of $884.00.

In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

I recommend buying Eli Lilly and Company stock after strong Q2 earnings, with technical indicators pointing to upward momentum. Click for more on LLY stock.

Fool.com contributor Parkev Tatevosian discusses the prospects for Eli Lilly stock. *Stock prices used were the afternoon prices of June 14, 2024. The video was published on June 16, 2024.

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

On Monday, Eli Lilly And Co (NYSE:LLY) announced results from the Phase 3 BRUIN CLL-321 trial evaluating pirtobrutinib in adult patients with chronic lymphocytic leukemia or small lymphocytic ...

Analyst Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target at $875.00. Mohit Bansal has given his Buy rating due to a ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, ... Eli Lilly's SWOT analysis: stock poised for growth amid challenges. 23h.

We came across a bullish thesis on Eli Lilly and Company on Stock Analysis Compilation’s Substack. In this article, we will ...